Companies, including healthcare entities, are responsible for complying with new and existing California laws and must take full accountability for their actions, decisions, and products.” ...
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
Cytokinetics has been a top biotech takeover candidate for some time, thanks to blockbuster speculation about its lead drug aficamten, but a $1 billion-plus set of financing deals shows it is ...
Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study.
Here below you have a complete description of its most interesting features and benefits so you can make the most of it. The majority of other information websites display prices of a single ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
The new year isn't even upon yet, and there's already so much new music to look forward to in 2025. Add into that expected new albums from Lady Gaga (LG7 will follow in the first half of 2025 ...
The week's most popular albums on independent labels, as compiled by Luminate, based on multi-metric consumption blending traditional album sales, track equivalent albums and streaming (audio ...
Amnesty International reported severe systematic human rights violations in Azerbaijan on Thursday. The report reflects the lack of improvement and the systemic nature of the abuses, including ...
bubbling under hot 100 the week’s most popular current songs across all genres below no. 100, ranked by streaming activity data by online music sources tracked by luminate, radio airplay ...